Alexion, AstraZeneca Rare Disease Address 2 Pancras Square, King’s Cross, London, N1C 4AG E-mail: UKcorporateaffairs@alexion.com Website: https://alexion.com/worldwide/UK This webpage has been created and paid for by Alexion, AstraZeneca Rare Disease and is intended for a range of UK audiences with an interest in healthcare policy including healthcare organisations, relevant decision makers and patient organisations. M/UK/NP/0112 Date of Preparation: January 2025 Alexion, AstraZeneca Rare Disease is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and delivery of life-changing medicines. More Close Alexion, AstraZeneca Rare Disease A pioneering leader in rare disease for more than three decades, Alexion was the first to translate the complex biology of the complement system into transformative medicines, and today it continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more people with rare disease around the world. It is headquartered in Boston, US.